ODM-102 / Orion Corp  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ODM-102 / Orion Corp
NCT01839019: Safety and Tolerability Study With Single Ascending Doses of ODM-102

Completed
1
22
Europe
ODM-102, Placebo for ODM-102
Orion Corporation, Orion Pharma
Healthy Volunteers
06/13
08/13

Download Options